Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 44-48

  Lokhorst, Henk M ^a   Sonneveld, Pieter ^b   Wijermans, Pierre W ^c   Van Marwijk Kooy, Marinus ^d   Meuwissen, Otger J A Th ^d   Van Oers, Rien H J ^e   Van Der Griend, René ^e   Dekker, Adriaan W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEYENBURG HOSPITAL   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Myeloma; Peripheral blood stem cell transplantation

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030068996     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00306.x     Document Type: Article

References (12)

1. Alexanian, R., Dimopoulos, M., Smith, T., Delasalle, K., Barlogie, B. & Champlin, R. (1994) Limited value of myeloablative therapy for late multiple myeloma. Blood, 83, 512-516.
2. Attal, M., Harrousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, G., Rossi, J.F., Casassus, P., Thijss, A., Maisonneuve, H., Facon, T., Ifrah, N. & Bataille, R. (1994) High dose therapy in multiple myeloma: a prospective randomized study of the Intergroupe Français du Myelome (IFM). Blood, 84, 386a (abstract 1530).
3. Barlogie, B., Jagganath, S., Vesole, D. & Tricot, G. (1995) Autologous and allogeneic transplants for multiple myeloma. Seminars in Hematology, 32, 31-44.
4. Cunningham, D., Paz-Ares, L., Gore, M.E., Malpas, J., Hickish, T., Nicolson, M., Meldrum, M., Viner, C., Milan, S., Selby, P.J., Norman, A., Raymond, J. & Powles, R. (1994a) High-dose melphalan for multiple myeloma: long-term follow-up data. Journal of Clinical Oncology, 12, 764-768.
5. Cunningham, D., Paz-Ares, L., Milan, S., Powles, R., Nicolson, M., Hickish, T., Selby, P., Treleavan, J., Viner, C., Malpas, J., Slevin, M., Findlay, M., Raymond, J. & Gore, M.E. (1994b) High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. Journal of Clinical Oncology, 12, 759-763.
6. Elsenmann, J.C. Hénon, P.H., Wunder, E., Lepers, M., Beck-Wirth, G., Debecker, A. & Prévot, G. (1990) Unequal results of collection of peripheral blood stem cells in view of autografting in high-risk multiple myeloma. Bone Marrow Transplantation, 5, 56-57.
7. Gore, M.E., Selby, P.J., Viner, C., Clark, P.I., Meldrum, M., Millar, B., Bell, J., Maitland, J.A., Milan, S., Judson, I.R., Zuiable, A., Tillyer, C., Slevin, M., Malpas, J.S. & McElwain, T.J. (1989) Intensive treatment of multiple myeloma and criteria for complete remission. Lancet, ii, 879-881.
8. Harousseau, J.L., Milpied, N., Jouet, J.P., Collombat, P., Gyotar, C., Guilhot, F., Laparte, J.P., Ifrah, C.N., Gandhour, C. & Casfassup, P. (1991) Intensive therapy for high grade multiple myeloma. Multiple Myeloma from Biology to Therapy (ed. by A. Pileri and M. Boccadoro), pp. 134-155. Lippincott, Philadelphia.
9. Lokhorst, H.M. & Dekker, A.W. (1995) Advances in the treatment of multiple myeloma. Cancer Treatment Reviews, 19, 115-28.
10. Lokhorst, H.M., Meuwissen, O.J.A.Th., Verdonck, L.F. & Dekker, A.W. (1992) High-risk multiple myeloma treated with high-dose melphalan. Journal of Clinical Oncology, 10, 47-51.
11. Selby, P.J., McElwain, T.J., Nandi, A.C., Perren, T.J., Powles, R.L., Tillyer, C.R., Osborne, R.J., Slevin, M.L. & Maplas, J.S. (1987) Multiple myeloma treated with high-dose intravenous melphalan. British Journal of Haematology, 66, 55-62.
12. Zubrod, C.G., Schneiderman, M., Frei, E., III, Brindley, C., Gold, L.G., Shnider, B., Oviedo, R., Gorman, J., Jones, R., Jr. Jonsson, U., Colsky, J., Chalmers, T., Ferguson, B., Dederick, M., Holland, J., Selawy, O., Regelson, W., Lasagna, L. & Owens, A.H., Jr (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases, 11, 7-55.